To validate the relevance of our findings to human CRC and to examine whether hindering eIF3f‐PHGDH signaling axis can restrain the CRC tumor formation, we performed cell growth studies and the results showed that both NCT‐503 and LGK‐974 (Wnt inhibitor) could suppress CRC foci formation. The gene discussed is EIF3F; the disease is neoplasm.